The FDA was currently reviewing the EUA application of Moderna, according to Domingo.
FDA Director-General Eric Domingo said that the Food and Drug Administration (FDA) was currently reviewing the application of Moderna for an emergency use authorization (EUA) of its COVID-19 vaccine.
In a report on Inquirer, the Food and Drug Administration was currently reviewing the application of Moderna for an emergency use authorization of its COVID-19 vaccine.
On Tuesday, Domingo confirmed in a text message to Inquirer that Moderna had applied for a EUA last Monday. According to Domingo, it was “still being checked” if Moderna had submitted complete documents for its EUA application.
Earlier, the FDA approved the emergency use in the Philippines of COVID-19 vaccines from Pfizer-BioNTech, AstraZeneca-Oxford, Sinovac Biotech, Gamaleya Institute, Janssen Pharmaceuticals, and Bharat Biotech.
The government and the private sector headed by Enrique Razon earlier signed a tripartite agreement with Moderna Inc to secure 20 million COVID-19 vaccine doses.
Under the said agreement, the national government will secure 13 million COVID-19 vaccine doses while the private sector will have 7 million COVID-19 vaccine doses for its workers.
Vaccine czar Secretary Carlito Galvez Jr. said that the Philippines had ordered an additional 5 million Moderna COVID-19 vaccine doses.
Meanwhile, Galvez on Monday virtually announced that Moderna — through Zuellig Pharma Corp. — had submitted its EUA application to the Philippine Food and Drug Administration.